Infectious Disease and Immunizations Flashcards

1
Q

Vaccine adverse events/side effects

A
  • MMR, varicella zoster, influenza, hepatitis B, meningococcal, and tetanus-containing vaccines are linked to anaphylaxis
  • Vaccines injections can cause syncope, fainting, deltoid bursitis, shoulder pain, and loss of shoulder motion
  • After MMR, febrile seizures and measles inclusion body encephalitis in immunocompromised children can occur within a year of vaccination
  • Varicella zoster vaccine has a causal relationship to some adverse events (Chickenpox rash; pneumonia, meningitis, and hepatitis in children with immunodeficiencies; viral reactivation leading to meningitis or encephalitis)

There is no substantiated evidence of a cause or relationship between vaccines and autism, ADHD, speech/language delays, childhood disintegrative disorder, Asperger syndrome, or Rett syndrome, and type I diabetes

Fever/local reactions within first 24 to 72 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

General vaccination guidelines

A
  • Doses may be given 4 days prior/later than specified date
  • If 2 live virus vaccines are given less than 28 days apart, the vaccine given second should be disregarded; repeat this second vaccine at least four weeks later
  • Do not aspirate the syringe before injection
  • When multiple vaccines are given on the same extremity, the sites of injection should be at least 1 inch apart
  • Use only written, dated records
  • Reimmunization of an immune individual is not harmful
  • Reduced or divided doses of vaccines should not be given
  • In some circumstances, an accelerated schedule is available from the ACIP
  • Vaccine failure can occur with improper transport and storage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contraindications to vaccines

A

The major vaccine contraindication is anaphylaxis with a prior dose or to a vaccine component

MMR, varicella zoster, influenza, hepatitis B, meningococcal, and tetanus-containing vaccines are linked to anaphylaxis

Anaphylaxis to prior dose, neomycin, polymyxin B, streptomycin - Contraindication to IPV

Pregnancy - Contraindication for HPV

Allergies to vaccines components/yeast - Contraindication for IPV and HepB

Moderate to severe infection - Contraindication for HPV and Hib

History of intussusception or SCID (severe combined immunodeficiency) - Contraindication for RV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CDC vaccine schedule

A

https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Inactivated vaccines

A

DTaP / Tdap

Polio (IPV)

Hib (Most virulent, accounting for pneumonia, bacteremia, meningitis, epiglottitis, septic arthritis, cellulitis, otitis media, purulent pericarditis, and other less common infections, notably in those younger than 4 years of age)

Hepatitis A (two-dose series)

Hepatitis B (premature infant born <2kg, give first dose at 1 month)

HPV (Gardasil-9 given to males and females ages 9-26 years)

Influenza (formulated yearly based on epidemiologic forecasts - annual vaccine starting at 6 months)

Meningococcal

Pneumococcal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Live virus vaccines

A

An individual with a low T-cell count or a cellular immunodeficiency can be seriously compromised if given a live vaccine

Vaccine timing after reduction or cessation of chemotherapy or administration of an immune globulin varies

  • MMR or MMRV
  • Measles
  • Mumps
  • Rubella
  • Varicella (localized pain and erythema; may develop maculopapular rash; postexposure prophylaxis should be provided within 10 days of exposure preferably within 96 hours)
  • Rotavirus (An estimated 4 out of 5 children are infected with rotavirus before five years old) - is a 2 or 3 dose oral series
  • Bacille Calmette-Guerin (BCG) - prevents spread of TB; not commonly used in the US
  • Smallpox (Not routinely used in US; reserved for preexposure or postexposure situations)
  • FluMist?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Passive immunity

A

Immunoglobulins

  • Reserved for those with immunodeficiencies or who have problems making antibodies
  • Given to non-immunized or under-immunized patients exposed to certain infectious diseases

Respiratory Syncytial Virus Prophylaxis - Palivizumab (Synagis)

  • Infants born before 29 weeks gestation during RSV season until they are 12 months old
  • Children born prematurely at or before 32 weeks who are younger than 2 years old with chronic lung disease (CLD) and who require treatment for their CLD within 6 months of the onset of RSV season; prophylaxis can be given to 2-year-old children with CLD of prematurity who continue to require medical support during the 6 months prior to the onset of RSV season
  • Infants up to 12 months old with hemodynamically significant cyanotic or complicated congenital heart disease
  • Infants up to 12 months old with neuromuscular disorder or congenital anomalies that compromise clearing of respiratory secretions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Infectious disease clinical findings on physical examination

A
  • Irritability is nonspecific in children
  • Stiff/painful neck (meningitis)
  • New murmur (endocarditis or rheumatic fever)
  • Refusal to walk (deep tissue infection, osteomyelitis, meningitis, or septic arthritis)
  • Skin/mucus membrane changes (common in viral illnesses)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Infectious disease diagnostics

A

CBC:

  • WBC: leukocytosis (high WBC) with bacterial infection; leukopenia (low WBC) with viral infection
  • Differential: bacterial - increased neutrophil and bands; viral - elevated lymphocyte count

Platelet Count:
- Thrombocytosis (elevated platelets) in active phase of acute infection

CRP:
- Acute-phase reactant; increases in presence of acute inflammation; nonspecific

Procalcitonin:

  • Biomarker for differentiating some viral from serious bacterial infections
  • Increased in bacteremia; can reflect severity

ESR:

  • Acute-phase reactant; nonspecific
  • Useful to evaluate therapy when antibiotics used
  • Useful in the fever of unknown origin (FUO)

Cultures, stains, antimicrobial susceptibility testing:

  • Bacterial, viral, fungal cultures
  • Susceptibility to antibiotics on cultures (especially UTI antibiotic choice)

DNA/RNA testing to assess for multiple organisms - PCR: STIs

Immunoserology:
- Detect antibodies to specific infectious organisms

Imaging techniques:

  • Diagnosis of infections in bone, sinus, lung, skin, viscera, brain, and heart
  • Radiographs, CT, MRI, echocardiography, US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CBC

A
Elevated WBC (leukocytosis) = bacterial
Decreased WBC (leukopenia) = viral
Bacterial = increased neutrophils and elevated bands
Viral = elevated lymphocyte counts and/or atypical lymphocyte production

WBC affected by long-term use of certain medications (some can decrease), age, steroid use (can increase), and clinical state (overwhelming sepsis can decrease WBC)

Chronic inflammatory processes can cause decrease in RBCs (anemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Platelet Count

A

Platelets elevated (thrombocytosis) = active phase of acute infection (with elevations in CRP and ESR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CRP

A

Increased in the presence of acute inflammation and specific pathogens

Normal = 0.0 - 0.05 mg/dL
Sepsis is much less likely to occur with CRP <10 mg/L

Serial CRPs 24-48 hours after onset of symptoms is recommended

Can help monitor body’s response to treatment

Inflammatory processes (maternal and perinatal factors, trauma, rheumatologic diseases, and oncologic diseases) can elevate CRP

Persistent elevations of CRP = treatment failure and conditions such as adiposity, use of birth control pills, and pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Procalcitonin

A

Biomarker that differentiates certain viral infections from serious bacterial infection

Increased in children with bacteremia and reflect the severity of illness

Higher sensitivity and specificity than CRP for predicting pyelonephritis, pneumonia, early-onset sepsis in premature infants, bacterial infection in febrile neutropenic children with cancer, diarrhea associated hemolytic-uremic syndrome, bacterial causes of acute hepatic disease, bacterial versus aseptic meningitis, and various diseases or conditions that involve inflammatory processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ESR

A

Measure of inflammation and reflects RBCs settling faster when acute phase proteins (such as fibrinogen) are present in serum than when they are not

Useful in evaluating fever of unknown origin (FUO) and like CRP, can be used to monitor therapy response

Low sedimentation rate (<10 mm/h) = Unlikely in bacterial infection as the cause of prolonged unexplained fever

Viral infections = mean ESR around 22 mm/h
Exception: adenovirus = values higher than 30 mm/h

ESR > 50 mm/h = warrants further evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Respiratory Bacteria and Viruses

A
-BACTERIA:
Hib
Neisseria meningitides
Group A Strep
Streptococcus pneumonia
Mycobacterium TB
Kingella kingae
- VIRUSES:
Adenovirus
Coronavirus
Influenza A and B
Measles
Mumps
Varicella-zoster
Metapneumovirus
Parainfluenza
Parvovirus B19
Respiratory syncytial virus (RSV)
Rhinovirus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fecal-oral Bacteria and Viruses

A
-BACTERIA:
Campylobacter jejuni
Salmonella spp.
Shigella spp.
Clostridium difficile
Aeromonas
Plesiomonas
E. coli
- VIRUSES:
Enteroviruses (genus Klebsiella)
Hepatitis A virus
Rotavirus
Calicivirus
Astrovirus
Norovirus (Norwalk)
Enteric adenovirus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Person-to-person via SKIN CONTACT with bacteria and viruses

A

-BACTERIA:
Group A strep (GAS)
Staphylococcus aureus

-VIRUSES:
Herpes simplex
Varicella-zoster
Molluscum contagiosum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Contact with blood, urine, or saliva

A
-VIRUSES:
Cytomegalovirus (CMV)
Hepatitis B and C
Herpes simplex
Human immunodeficiency virus (HIV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Enteroviruses (non-polio)

A
  • Most common cause of aseptic meningitis
  • Coxsackievirus B?
  • Hand-foot-mouth, herpangina, acute hemorrhagic conjunctivitis
  • Primary invasion through G.I. tract
  • Transmitted via respiratory route
  • Transplacental transmission can occur

Hx: Mild URI; nonspecific febrile illness >3 days; onset within two weeks after delivery

PE:

  • Skin: macular, maculopapular, urticarial, vesicular, petechial
  • Herpangina (Sudden onset of my fever; vesicular lesions on oropharynx and palate)
  • Acute lymphonodular pharyngitis
  • Hand-foot-mouth disease (vesicles)
  • Aseptic meningitis (fever, stiff neck, headache)
  • Pleurodynia (sudden occurrence of lancinating chest pain or abdominal pain attacks)
  • Orchitis (similar to mumps)
  • Myocarditis/pericarditis (mild to severe)
  • Respiratory - wheezing, asthma exacerbation, apnea, distress

Dx: PCR highly sensitive; cultures from throat, stool, CSF, and blood

Diff Dx: viral/bacterial causes

Management: supportive care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Enteroviruses (poliomyelitis)

A

Asymptomatic illness to severe CNS involvement

Fecal-oral/respiratory transmission

Nonspecific febrile illness, aseptic meningitis, paralytic symptoms

Dx: Viral culture from stool/throat (two samples 24 hours apart)

Management is supportive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hepatitis A Virus

A

Causes primary infection in liver

Person-to-person; fecal-oral transmission

Only 30% are symptomatic (Allows for rapid spread)

Clinical findings:

  • Preicteric phase - acute febrile illness, malaise, nausea, anorexia, vomiting, digestive complaints, RUQ pain
  • Icteric phase - jaundice, dark urine, clay-colored stools, feel sick, poor weight gain an infants
  • Complete recovery in 1 to 2 months; occasional relapses up to six months

Dx: serologic testing

Management, complications, prevention:

  • Supportive care and good hand hygiene
  • Immunoglobulin or HAV vaccine within two weeks of exposure
  • Good personal hygiene; safe drinking water
  • Routine HAV vaccine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hepatitis B Virus

A

Highly contagious

Causes severe liver damage

Blood/body fluids transmission; perinatal transmission can occur

> 90% of infants will develop chronic illness if untreated

Clinical findings:

  • Most asymptomatic at early age
  • Fever, nausea, mild hepatomegaly
  • Later - more severe icteric phase

Dx: serologic testing; LFT evaluate degree of injury

Management:

  • Acute infection - supportive care
  • Active and passive vaccination
  • Specialist for chronic management
  • Five medications approved for use in children
23
Q

Hepatitis C Virus

A

Spread through blood (IV drug use = most common in US); perinatal transmission is major route for children

15-25% do not develop chronic disease; will resolve spontaneously without treatment

High rate of chronic disease - liver damage

Clinical findings:

  • Incubation - 2 weeks to 6 months
  • Severe or sudden infection uncommon

Dx: no serologic marker; IgG antibody enzyme immunoassay but may have false neg; LFT when disease occurs

Management:

  • Supportive
  • Interferon for chronic disease
  • HAV and HBV vaccine to prevent further complications
24
Q

Hepatitis D and Hepatitis E

A

Hepatitis D

  • Uncommon in children
  • Parenteral, percutaneous, or mucosal contact with infected blood
  • No vaccine
  • HBV vaccine because HDV requires comorbidity with HBV

Hepatitis E

  • Human, nonhuman host
  • Fecal-oral transmission; contaminated water
  • Asymptomatic/mild symptoms in children
  • Chronic infection rare
25
Q

HSV

A
HSV1 = orolabial lesions (most common in children; presents as gingivostomatitis)
HSV2 = genital lesions (usually result of sexual activity)

Neonatal HSV2 from delivery

  • Through conjunctiva, nose/mouth, or broken skin
  • Can occur with c-section; asymptomatic shedding

Communicability is 2 days to 2 weeks
Some perinatal infection occur >6 weeks after birth

NEONATAL INFECTION: always symptomatic

  • Disseminated - multiple organ failure, encephalitis (day 10-12 of life)
  • CNS: Focal/generalized seizures, lethargy, irritability, poor feeding, herpetic lesions (day 16-19 of life)
  • Skin, eye, mouth - limited to these sites (day 10-12)

TRAUMATIC HERPETIC INFECTION

  • Localized to the area of abrasion, teething, laceration; Inoculated by parent who kisses site
  • Fever, constitutional symptoms, regional lymphadenopathy

ACUTE HERPETIC MENINGOENCEPHALITIS

  • HSV-1 is leading cause of intermittent nonepidemic encephalitis in the US
  • HSV-2 can cause benign HSV meningitis

Recurrent infection: virus is dormant; recurrent infections are common

Dx: Intrapartum cultures; within 12-24 hours after delivery

Management: parenteral acyclovir with life-threatening/neonatal infection; oral acyclovir for 6 months after parenteral treatment

  • Refer all children with ocular involvement
  • Monitor ANC (if neutropenia occurs, stop therapy until count recovers then start back therapy)

Toddler/infants with gingivostomatitis should be kept out of daycare if drooling; “fever blisters” may go to school

Wrestlers should not compete until lesions clear

Ask all pregnant women about HSV during labor

26
Q

EBV (“mono”)

A

Herpes family of viruses

Older children/adolescents common
Acute illness for 2-4 weeks

Clinical findings:

  • Lymphoid tissue enlargement (Spleen, nodes, tonsils, liver)
  • Atypical lymphocytes in peripheral blood
  • Prodrome (mild; malaise; fatigue)
  • Acute (fever, sore throat, malaise, fatigue, rash, organomegaly)
  • Resolution (gradual resolution with organomegaly taking 1 to 2 months to resolve; fatigue can continue for 6 months)
  • Oral hairy leukoplakia (gray exudate on tonsils)
  • Morbilliform rash in response to antibiotics
  • Supraorbital edema in 10-20% of patients

Dx: CBC (>10% atypical lymphocytes); elevated liver enzymes; monospot, serum heterophile test; check EBV antibodies

Diff dx: GABHS, CMV, rubella, SLE, leukemia, toxoplasmosis

Management: usually no treatment; supportive, bed rest, OTC analgesics, fluids, calories; return-to-play guidelines after hepatosplenomegaly (wait at least 4 weeks)

Education: no blood/organ donation after recent infection; avoid sharing food/drink

27
Q

Roseola Infantum

A

Herpes family of viruses (human herpesvirus - HHV-6 and HHV-7)

Likely spread via oral, nasal, conjunctival routes

Most common between 7 to 24 months (rare <3 months and >4 years)

Clinical findings: sudden onset of fever for 3 to 7 days without seeming ill; at defervescence, rose-colored maculopapular rash

Dx: made on presentation

Diff dx: other viral rashes; scarlatina; drug hypersensitivity

Management and complications:

  • Supportive; acetaminophen
  • No prevention
  • Rare complications: febrile seizures, meningoencephalitis
28
Q

Varicella

A

Herpes family of viruses

Highly contagious - Chickenpox primary illness

Shingles - (herpes zoster) reactivation of latent VZV acquired during varicella infection

Direct contact, droplets, airborne transmission

Victims of shingles infectious (Can cause primary varicella illness)

Incubation period = 10-21 days
Communicability is 1 to 2 days before rash erupts until lesions crust over (3-7 days)

Clinical findings:

  • Prodrome - not always present; low-grade fever, anorexia, mild abdominal pain
  • Rash (in crops of pruritic lesions; macular spot to teardrop vesicles; vesicles break open and crust over) - all forms can be present at once and on mucosal tissues; high fever

Dx: PCR or direct fluorescent antibody testing; serology for IgG

Diff dx: impetigo; cigarette burns; insect bites

Management:

  • Supportive
  • Antihistamines; oatmeal baths for itching
  • Acetaminophen for fever
  • Topical antibiotics for bacterial superinfection
  • IV acyclovir for immunocompromised patients
  • Oral acyclovir not routinely recommended

Complications:

  • Pyoderma - strep/staph
  • Pneumonia, CNS complications, glomerulonephritis, hepatitis

Education: may attend school for up to one week after exposure unless signs of illness; immune globulin for immunocompromised patients; should receive vaccine within 5 months

29
Q

Influenza virus

A

Orthomyxovirus (type A, B, C)

Typical influenza: mortality rate 0.5-1/1000; Incubation period 1 to 4 days; infectious 24 hours before symptoms until 7 days after onset

Clinical findings:

  • Sudden onset of high fever, headache, chills, coryza (runny nose), vertigo, sore throat, myalgia, dry cough
  • Young children may have N/V, croup
  • Infants will appear septic
  • Conjunctival infection, epistaxis (nose bleed), myocarditis (inflammatory cardiomyopathy) common
  • Lower resp tract involvement with severe infection (death from pneumonia)

Dx: viral cultures; rapid tests have limited sensitivity

Diff dx: other viral URI; allergic croup; bacterial pulmonary infections

Management:

  • Supportive (Bed rest, OTC antipyretics, fluids)
  • Viral resistance to amantadine/rimantadine (antivirals used to treat certain types of flu virus) - need reliable susceptibility
  • Antiviral therapy for immunocompromised or those with chronic diseases at risk for complications (only decrease s/sx by 1 day but can cause suicidal thoughts)

Complications: Reye syndrome (acute condition that causes swelling of brain and liver), resp infections, acute myositis, myocarditis, asthma/CF exacerbations

Education: annual flu vaccine

30
Q

HIV

A

Increased rates in 13 to 14-year-olds and 20 to 29-year-olds

Transmission greatest for male-to-male sexual contact

Vertical transmission (mother to infant) higher in non-Hispanic African-Americans

Virtual elimination of mother-to-infant transmission in the US due to: rigorous antenatal screening; use of cART (combination anti-retroviral treatment); cesarean births; not breastfeeding

Elective C-section with zidovudine (Retrovir) for mother and infant decreases risk by 87%

Risk factors: maternal drug use; PROM; low birth weight; birth < 34 weeks

Clinical findings:

  • Influenza-like symptoms for 2-4 weeks
  • Asymptomatic for months to 15 years
  • Lymphadenopathy, hepatomegaly occur first
  • FTT, diarrhea, pneumonia, recurrent infections
  • Opportunistic diseases occur (Mycobacterium avium, severe CMV, EBV, VZV, histoplasmosis, TB)
  • Children: more recurrent bacterial infections, parotid gland swelling, lymphoid interstitial pneumonitis (lymphocyte predominant infiltration of the lungs)
  • Malignancies common in pediatric AIDS

Dx: Newborn HIV testing (Refer to pediatric HIV specialist is screening normal, but high suspicion remains)

Management: Follow current CDC AIDS info guidelines; treatment in consultation with HIV specialist

  • Current cART - at least 3 oral ARV drugs from at least 2 drug classes (two NRTIs plus either NNRTI or PI, often with low-dose ritonavir)
  • Treat the associated conditions with IVIG, antifungals, antivirals, antimycobacterials, nutrition counseling
  • Infants discharged from hospital with full 6 week course of zidovudine in hand
  • Infant with unknown exposure or infected should be prescribed trimethoprim-sulfamethoxazole (TMP-SMX) for prophylaxis against Pneumocystis jirovecii starting at 4-6 weeks old until 1 year old

PCP role: help boost adherence rates

31
Q

HIV transmission risk factors to infant

A
  • maternal drug use
  • PROM
  • Low birth weight
  • < 34 weeks

Transmission through breastmilk depends on:

  • maternal status, symptoms, CD4+ cell count
  • length of time breastfeeding
  • infant co-infections
  • breast abscesses, mastitis, cracked nipples
32
Q

At what point infections are contagious/no longer contagious

A
  • HSV: communicability 2 days to 2 weeks (for non-neonates)
  • Varicella: 1 to 2 days before rash erupts until lesions crust over (3-7 days)
  • Influenza: 24 hours before symptoms until 7 days after onset
  • Rubeola/measles: 1 to 2 days before onset of symptoms to 4 days after appearance of rash
  • Mumps: 1 to 2 days before swelling and up to 5 days after onset of symptoms
  • Erythema infectiosum “Fifths disease”: (rash and symptoms occur 2-3 weeks after exposure) communicable highest before appearance of rash
  • Parainfluenza (hPIV): 4-6 days before symptoms and 7-21 days after resolution; virus lives on non-porous surfaces for up to 10 hours
33
Q

Measles (rubeola)

A

REPORTABLE Morbillivirus in the Paramyxoviridae family (Causative organism is measles virus itself or group A beta-hemolytic streptococci/GABHS, pneumococci, H. influenzae, or S. aureus)

Characteristic rash indicating viremia; serious disease

Transmitted through respiratory secretions, blood, urine

90% of susceptible individuals will develop disease when exposed

  • Incubation period: 8 to 12 days
  • Contagious 1 to 2 days before onset of symptoms (3-5 days before rash) to 4 days after appearance of rash, or roughly 14 days (range 7-18 days)

Clinical findings:
- Incubation period: no symptoms
- Prodromal period (4-5 days): URI symptoms, low to moderate fever, cough, runny nose, conjunctivitis, koplik spots (bluish white granules on erythematous background on buccal mucosa)
3 Cs: cough, coryza, and conjunctivitis
- Rash stage (day 3-4): maculopapular rash behind ears and on forehead; papules enlarge and progress downward; high fever; respiratory symptoms worse day 3 of rash; rash may become hemorrhagic (DIC with bleeding from mouth, nose, and bowel)

Dx: IgM or viral isolation (REPORTABLE DISEASE)

Diff dx: any viral rash, toxoplasmosis, scarlet fever, Kawasaki syndrome, meningococcemia, Rocky Mountains spotted fever (RMSF), drug rashes, and serum sickness

Management:

  • Supportive care (antipyretics, bed rest, adequate fluids, air humidification, warm room, darkened room if photophobia present)
  • Refer to infectious disease specialist if immunocompromised or severe symptoms (off-label use of ribavirin)
  • Vitamin A therapy to prevent complications

Vaccine within 72 hours (infants 6-11 months old) or IG within 6 days of exposure to prevent/modify disease in susceptible patients (Call all patients in office that day)

Complications: bacterial superinfection (URI, obstructive laryngitis, otitis, diarrhea, mastoiditis, cervical adenitis, bronchitis, transient hepatitis, and pneumonia (largest cause of fatality in infants), myocarditis, purpura fulminans (“black measles”), encephalitis

34
Q

Mumps

A

Acute viral disease; painful enlargement of salivary (usually parotid) glands

In the Paramyxoviridae family

Transmission through saliva, respiratory secretions

Incubation: 12 to 25 days
Communicability: 1 to 2 days before swelling up to 5 days after onset of symptoms

Lifelong immunity after infection

Clinical findings:

  • Prodromal (rare) - Fever, headache, anorexia, neck pain, malaise
  • Swelling stage (one or both parotid glands) and orchitis (inflamed testicles) in males after puberty; “pickle sign”; Stensen and Wharton ducts red and swollen

Dx: viral detection; serologic tests; leukopenia (low WBC)

Diff dx: lymphadenitis, CMV, HIV, enteroviruses, tumor, suppurative parotitis

Management: supportive care; corticosteroids or NSAIDS

Complications: meningoencephalitis, orchitis, epididymitis, oophoritis (inflammation of ovaries), myocarditis, deafness

35
Q

Erythema Infectiousum (“Fifths disease”)

A

Caused by parvovirus B19

Vertical transmission, respiratory secretions, percutaneous exposure

Disease of childhood (5-15 years)

Incubation: 4-21 days
Rash 2-3 weeks after exposure
Communicable before appearance of rash

Clinical findings:

  • Prodrome - mild fever, myalgia, headache, malaise, URI symptoms
  • Rash - 7 to 10 days after prodromal stage (slapped cheek with circumoral pallor)
  • Then lacy, maculopapular rash may last 1 month (on trunk then moves peripherally; not on palms and soles)

Dx: not usually indicated

Management: no antiviral treatment; transfusion for those with hemolytic anemia or immunocompromised; IGIV for immunocompromised; children in rash stage may attend school; pregnant women may develop fetal hydrops, death, or IUGR

36
Q

Parainfluenza Virus

A

Similar to influenza virus; important cause of laryngotracheobronchitis (croup), bronchitis, bronchiolitis, pneumonia

Naso-pharyngeal secretions and fomites

Accounts for 7% of hospital admissions in children < 5 years old

Type 1 and 2 - children 1-5 years (usually croup)
Type 3 - children under 12 months (bronchitis, bronchiolitis, and pneumonia)
Type 4 - mild to severe resp illness

Incubation: 2-6 days
Contagious 4-6 days before symptoms and 7-21 days after resolution

Clinical findings: acute onset of mild fever, sore throat, rhinitis, hoarseness, and cough; lower respiratory involvement (dyspnea, crackles, wheezing, and hyperaeration)

Dx: RT-PCR assays from nasopharyngeal secretions

Management: supportive; most uncomplicated; antibiotics if secondary bacterial infection

37
Q

Rubella (German Measles)

A

Spread through nasopharyngeal secretions or transplacentally

RNA virus

Prolong, repeated contact to become infected

Incubation: 14 to 21 days
Viral shedding 5 days before to 6 days after rash appearance

Clinical findings:

  • Prodrome: mild fever, G.I. upset, sore throat, eye pain, arthralgia, malaise, headache
  • Lymphadenopathy: postauricular, posterior cervical, and posterior occipital nodes; splenomegaly
  • Rash: enanthem (small; rose-colored spots on soft palate); then rubella rash begins on face then spreads with complete remission by 3rd day

Dx: clinical signs; RT-PCR; IgG; IgM; antibodies

Management: supportive, antipyretics; keep home from daycare/school about 1 week after rash erupts

38
Q

West Nile Virus

A

Mosquito-borne, rare human-to-human

Symptoms 2 to 14 days after bite; more frequently affects children > 10 years

Clinical findings: mimics influenza; G.I. infection; mild symptoms will resolve in one week; severe - neuroinvasive involvement

Dx: IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA)

Management: supportive treatment for mild cases; hospitalization with meningitis, encephalitis, severe muscle weakness/paralysis, dysphasia, dysarthria; antiretrovirals not indicated

Education: use DEET (not < 2 months); minimize standing water; tight-fitting screens on doors and windows; reports dead birds to health agencies

39
Q

Dengue Virus

A

Mosquito-borne virus

Clinical findings: question about travel; ask about 24 hour fluid intake; dizziness, urinary output, diarrhea

  • Febrile phase: rapid rise; 2-7 days
  • Critical phase: mild to severe plasma leak - dengue hemorrhagic fever; spontaneous bleeding, anemia; progression to “shock syndrome”
  • Recovery phase: Reabsorption of extravascular fluid for 48 to 72 hours

Dx: CBC, platelets, hematocrit; Serum urea >4.0 (dehydration) and total protein <6.7 (plasma leakage) signifies high risk hemorrhagic shock; viral, serology, and molecular tests

Management: current diagnosis/rapid treatment; hospitalized or follow daily during febrile phase

Complications: dehydration; fever can cause neurological disturbances/febrile seizures

40
Q

Hantavirus Pulmonary Syndrome

A

Rare in the US; Exposure to rodents

41
Q

Other noteworthy viruses

A

Metapneumovirus = Acute resp infection

Human calicivirus (norovirus; sapovirus) = gastroenteritis; occur in closed populations

Coronavirus = resp tract infections; severe acute respiratory syndrome (SARS-CoV)

Middle-Eastern Respiratory Syndrome (MERS): countries near Arabian peninsula
- Symptoms: systemic fever, muscle pain, cough, shortness of breath, expectoration, diarrhea, abdominal pain

42
Q

Lyme Disease

A

Tick-borne disease (caused by borrelia burgdorferi - a spirochete)

Clinical findings:

  • Stage 1 - typical rash (erythema migrans or “bull’s eye”); some may have flu-like symptoms
  • Stage 2 - early disseminated disease (Secondary annular lesions, neurologic signs, cardiac signs, generalized manifestations) for weeks to 2 years without treatment
  • Stage 3 - late disease (pauciarticular to monoarticular arthritis weeks to months after bite)

Dx: EM >5cm; IgM not positive for 2-4 weeks; IgG for 4-6 weeks
- CDC 2-step approach: ELISA blood test or indirect IFA (if negative, no further tests) & IgG and IgM Western blot if symptoms < 30 days

Management: prophylactic doxycycline/amoxicillin; early or late disseminated disease – consult with ID

43
Q

Ehrlichiosis and Anaplasmosis

A

Tickborne disease (caused by amblyomma americanum and scapularis)

Clinical findings:

  • Fever, headache, myalgia, malaise, chills, nausea, anorexia
  • Ehrlichiosis - rash (petechial, macular, maculopapular - sparing the hands and feet)

Dx: IFA assay

Tx: doxycycline for all ages

44
Q

Rocky Mountain Spotted Fever

A

Rickettsia rickettsii

Prompt removal of tick lowers risk of infection

Clinical findings: fever, chills, myalgia, G.I. symptoms, photophobia, altered mental state

  • Focal neurologic deficits with disease progression (paralysis, transient deafness)
  • Maculopapular rash on wrists, forearms, ankles (sometimes palms and soles); spreads to trunk

Dx: PCR or IFA
-CBC: thrombocytopenia, hyponatremia, leukocytosis, anemia

Management: antibiotics prior to onset of rash; doxycycline for 7 to 10 days for all ages

45
Q

MRSA

A

Causes pneumonia, cellulitis, osteomyelitis, myositis, bacteremia, endocarditis, TSS, deep tissue abscess, necrotizing fasciitis

Clinical clues: Boil, abscess without pus; rapid onset; fails treatment with beta-lactam agent; neonate with skin/soft tissue infection; attends daycare and < 2 years old; other family members with similar infection; recurrent small, nontender, maculopapular lesion

Management:

  • Superficial skin lesions: topical antibiotic
  • Widespread impetigo: Oral/IV antibiotics
  • I&D/Culture for nondraining, fluctuant abscess (abx not needed if mild)
  • Gram stain, culture/sensitivity, “d-test”
  • Warm compresses to localize pus in non fluctuant
  • Abx (Table 31.6 - pg 493): Clindamycin, doxycycline, minocycline, linezolid, trimethoprim-sulfamethoxazole (TMP-SMX)
46
Q

Cat-Scratch Disease (B. henselae)

A

Common cause of chronic, persistent lymphadenopathy in children

Clinical findings: 3 to 5 mm erythematous papules which heal; lymphadenopathy in 1 to 4 weeks; persists up to one year
- Parinaud oculograndular syndrome (painful nonsuppurative conjunctivitis)

Dx: IFA for serum antibodies; CBC - mild leukocytosis; ESR/CRP elevated early

Management: most resolve spontaneously; antibiotics only if concerned for systemic CSD

  • Treatment in immunocompromised patients: oral agents and parenteral gentamicin
  • Wash cat scratches with soap and water`

Complications: small percentage have systemic illness with high fever, malaise, fatigue, anorexia; enlarged mediastinal nodes; splenic/hepatic abscesses

47
Q

Kingella Kingae Infection

A

Important cause of invasive infections in children >6 months and <4 years

Organism part of normal flora in pharynx and children > 6 months; easily transmitted in childcare settings

Most common cause of septic arthritis in children < 3 years

Susceptible to many antibiotics (penicillins, aminoglycosides, ciprofloxacin, and erythromycin), but resistant to clindamycin/vancomycin
Most strains susceptible to TMP-SMX despite resistance to trimethoprim alone

48
Q

Meningococcal disease (N. meningitidis)

A

Respiratory tract secretions; epidemics in semi-closed communities (daycare)

Clinical findings: occult bacteremia (fever, URI and GI symptoms, maculopapular rash); meningococcemia (fever with signs of septic shock); meningococcal meningitis (fever, HA, stiff neck)

Dx: positive culture/ gram stain from CSF, blood, or synovial fluid; PCR assays useful if abx given

Management: hospitalization mandatory; IV antibiotics pending cultures

Control measures:
Chemoprophylaxis (within 24 hours of index case regardless of immunization status)
- Oral rifampin or ciprofloxacin for infants and children
- Single-dose azithromycin for ciprofloxacin-resistance
Prophylaxis during outbreak (vaccination and chemoprophylaxis)

49
Q

Group A Strep (GAS)

A

Upper respiratory tract secretions

Streptococcal pharyngitis common in winter and early spring; rare among children <3 years

Incubation period: 2-5 days for pharyngitis; 7-10 days for skin infections
Considered noninfectious 24 hours after the start of appropriate antibiotic therapy

Clinical findings:

  • Respiratory tract infection– peritonsillar abscess, cervical lymphadenitis, GABHS
  • Scarlet fever (erythrogenic toxin; Abrupt illness with sore throat, fever, vomiting, headache, chills, malaise, erythematous tonsils/exudate, strawberry tongue, sandpaper rash
  • Bacteremia – meningitis, septic arthritis, pneumonia
  • Vaginitis and TSS
  • Perianal streptococcal cellulitis
  • Skin infections
  • Rheumatic heart disease
  • Necrotizing fasciitis

Management: antimicrobial therapy to decrease risk of complications (PANDAS = OCD, tic, Tourettes)

Other complications: acute poststreptococcal glomerulonephritis, acute rheumatic fever, poststreptococcal reactive arthritis, other invasive infections

50
Q

Tuberculosis

A

Converting from negative to positive Mantoux TST skin test or positive IGRA

Progression of disease highest in infants, 15-25 years, and older adults

Clinical findings:

  • Primary pulmonary TB – Low-grade fever, nonproductive cough, decreased appetite, weight loss or FTT, night sweats
  • 25-30% will have extrapulmonary symptoms

Dx: TB skin test and IGRA assays

Management: consultation with TB specialist; report to health department; anti-tubercular drug treatment with strict adherence to drug regimen (isoniazid, rifampin, ethambutol - most common)

51
Q

Helminthic Zoonoses

A

Transmission by: direct infection by ingestion of eggs/penetration larvae into body; indirect infection by ingestion of food; exposure to intermediate vector

Toxocariasis (in dogs/cats):

  • visceral larva migrans, ocular larva migrans, covert disease
  • consider in any child with nonspecific hx of recurrent abdominal pain, reactive airway disease, allergies of unknown cause
52
Q

CHILD WITH FEVER

A

Two situations of particular challenge in community, infant, and children

  • 36 months or younger: Fever without a cause
  • In all ages: Fever of unknown origin (FUO)

Infants < 3 months: cause is usually viral; must still work up for a bacterial disease

Hib vaccine: occult bacteremia <0.5% for streptococcus pneumoniae

53
Q

Fever Without Cause

A

Birth to 24 months at greatest risk

Most common pathogens: See Table 31.8 (pg 503)

Febrile toxic child < 36 months with bacteremia, UTI, meningitis, bacterial gastroenteritis, or pneumonia = admit to hospital and empiric antibiotics

Negative, low-risk workup results:

  • WBC < 15,000; bands < 1500; Non-elevated ESR/CRP
  • Cath UA <10 WBC and neg leukocytes/nitrites
  • Fewer than 5 WBCs in stool
  • Negative chest XR with cough present
  • Cultures monitored every 24 hours
  • Viral testing based on seasonality

Management: applying risk criteria

High risk:

  • Febrile infant <1 month; Any toxic appearing newborn, infant, or child
  • Infant 1-3 months with fever
  • Infant 1-3 months with chronic illness or unreliable caretakers
  • Infant <3 months even with focal sign
  • Infants/children 3-36 months with temp >39C/102F and high-risk lab results
  • Child of any age with fever, petechiae, and ill-appearing

Low risk:

  • 1-3 months, nontoxic, low-risk dx results
  • 3-6 months, fever <39C, not ill-appearing
  • 3-36 months; fever >39C; not ill-appearing; previously healthy; focal signs; positive flu A
  • 3-36 months; mildly ill; fever >39C; low-risk diagnostic results; documented Hib vaccine

Follow up for any child not hospitalized:

  • Reevaluation in 24 hours; access to ED
  • Daily follow-up on cultures
  • See immediately if cultures positive
  • Detailed instructions for parent on what to do
54
Q

Fever of Unknown Origin

A

Fever present most days for >3 weeks

No etiology despite workup

Recommend infectious disease consult

Many are presentations of infections, rheumatological/connective tissue disease, or neoplastic disease

Most common in children (infection): UTI/pyelonephritis, respiratory illness, localized infection
Most common in adolescents (autoinflammatory or autoimmune): TB, IBD, autoimmune disorders, lymphoma